Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||0.09%||69.71||1.0%||$515.13m|
|VRTX||Vertex Pharmaceuticals, Inc.||0.68%||206.61||1.9%||$454.10m|
|REGN||Regeneron Pharmaceuticals, Inc.||2.98%||654.04||2.7%||$419.38m|
|SNSS||Sunesis Pharmaceuticals, Inc.||1.16%||4.36||0.7%||$304.78m|
|EXAS||EXACT Sciences Corp.||3.48%||86.26||18.0%||$150.95m|
|BMRN||BioMarin Pharmaceutical, Inc.||2.62%||88.38||4.2%||$138.75m|
Acceleron Pharma, Inc. operates as a biopharmaceutical company. The company engages in developing, manufacturing, and commercializing novel biotherapeutics that modulate the growth of bone, muscle, fat, and the vasculature to treat musculoskeletal, metabolic, and cancer-related diseases. Its products include ACE-011 Program, a novel bone forming agent that helps to treat cancer-related bone loss; ACE-031 Program that helps to treat diseases involving the loss of muscle mass, strength, and function in diseases, including muscular dystrophy, amyotrophic lateral sclerosis, and cancer-related muscle loss; and ACE-041, a protein therapeutic that binds a member of the growth and differentiation factor family necessary for angiogenesis. It develops therapies based on growth and differentiation factors that regulate the cellular proliferation, differentiation, and survival of a range of tissue types. The company offers treatments for cancer-related bone loss, cancer-related muscle loss, neuromuscular diseases, and metabolic disorders. Acceleron Pharma, Inc. was founded in 2003 and is headquartered in Cambridge, Massachusetts.